Today: 8 June 2026
Browse Category

NASDAQ:AZN 1 October 2025 - 1 March 2026

Nasdaq Nordic Week Ahead: OMXS30 ends February at 3,222.75 as PMIs, inflation and U.S. jobs loom

Nasdaq Nordic Week Ahead: OMXS30 ends February at 3,222.75 as PMIs, inflation and U.S. jobs loom

Stockholm’s OMXS30 closed Friday up 0.55% at 3,222.75, hitting a record high, while the OMX Nordic 40 rose 0.61% to 2,617.28. Ericsson gained 2.9%, with Boliden and AstraZeneca also rising over 2%. SEB fell 1.6%. Traders now await Swedish PMI and inflation data, plus the upcoming U.S. payrolls report.
1 March 2026
············
AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom

AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom

AstraZeneca will be removed from the Nasdaq-100 on Jan. 20, replaced by Walmart, Nasdaq said Friday. AstraZeneca shares rose 0.28% in London and 0.68% in New York after the announcement. Index funds are expected to adjust holdings near the effective date, potentially increasing trading volume. AstraZeneca management is set to speak at the JPMorgan Healthcare Conference starting Monday.
11 January 2026
····
AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next

AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next

Nasdaq said Friday that Walmart will replace AstraZeneca in the Nasdaq-100 before trading opens Jan. 20. AstraZeneca’s U.S. shares closed at $94.65, up 0.68%, with volume near 6.1 million. Investors are watching AstraZeneca’s management talks at the J.P. Morgan Healthcare Conference Jan. 12–14 and its full-year results on Feb. 10.
10 January 2026
···
AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca shares traded near £127.82 ($85 ADR) on Oct. 10, 2025, close to a 52-week high after a U.S. NYSE listing and a $4.5 billion Virginia plant announcement. Market cap stands at $264 billion, with 2024 revenue of $54.1 billion, up 18%. The company agreed to provide U.S. Medicaid with its lowest global drug prices. Shares have rallied over 10% since late September.
11 October 2025
···
Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

U.S. stocks closed at record highs despite a partial government shutdown, with the S&P 500 up 0.34% to 6,711.20 and the Dow rising 0.09% to 46,441.10. Health-care shares jumped after Pfizer and the White House struck a drug price deal, sending Biogen up 10.9%. The ADP report showed private-sector jobs fell by 32,000 in September, but investors bet on Fed rate cuts.
1 October 2025
·····

Stock Market Today

  • Nvidia Stock Forecast: Potential to Reach $300 by 2027 Amidst Strong AI-Driven Growth
    June 8, 2026, 5:00 PM EDT. Nvidia (NASDAQ: NVDA) posted a remarkable Q1 FY27 with revenue surging 85% year-on-year to $81.6 billion and free cash flow hitting $48.55 billion. Despite this, shares trade at $205.10, presenting a forward price-to-earnings (P/E) ratio of 26, below the 38x needed to reach $300 by 2027, per Wall Street's consensus target of $298. Nvidia's growth is propelled by AI infrastructure spending, with Q2 revenue guidance at $91 billion and $119 billion in supply commitments. Challenges include geopolitical issues in China and market sensitivity, but analyst sentiment remains 95% bullish. Our model predicts a $255 base case by mid-2027, reflecting 25% upside, while the $300 target requires significant earnings per share growth and multiple expansion. Nvidia remains a key player in AI and data center sectors.

Latest articles

IonQ Jumps as Quantum IPO Rush Sets Wall Street Benchmark

IonQ Jumps as Quantum IPO Rush Sets Wall Street Benchmark

8 June 2026
IonQ surged 10.5% to $62.77, outpacing quantum peers after Quantinuum’s $1.68 billion Nasdaq IPO gave investors a new benchmark for trapped-ion quantum stocks; IonQ’s rally follows its May guidance raise and soaring revenue, but losses and a long commercialization timeline remain key risks.
Snap Shares Climb as Debt Markets Send Signal

Snap Drops Again as Wall Street Stays Wary

8 June 2026
Snap plunged 2.1% to $5.64, underperforming a tech rebound, as investors weighed improved cash flow and a recent S&P credit upgrade against ongoing ad-market pressure, cost cuts, and spending on Specs; the stock’s weakness stood out as peers like Pinterest gained, highlighting market doubts about Snap’s ability to sustain growth amid tough competition and uncertain ad budgets.
Dow Drops After Hours, AI Rally Sidesteps Blue Chips

Dow Drops After Hours, AI Rally Sidesteps Blue Chips

8 June 2026
The Dow Jones fell 104.70 points, or 0.21%, to 50,762.08 as tech and chip stocks rebounded sharply, with the Philadelphia SE Semiconductor Index up 6.2% after Friday’s $1 trillion selloff; Apple dropped 1.4% despite its AI event, and investors now await Wednesday’s inflation data and Middle East energy risks as the next key tests for the market’s fragile rebound.
Nasdaq rises as AI names find support after market selloff

Nasdaq rises as AI names find support after market selloff

8 June 2026
Nasdaq surged 1.27% as investors snapped up AI and chip stocks after Friday’s rout, with the Philadelphia Semiconductor Index jumping 6.2%; Citigroup hiked its S&P 500 year-end target to 8,100 on AI demand, but Goldman Sachs warned strong jobs data makes a Fed rate hike more plausible, posing risks to growth stocks if inflation surprises.
Go toTop